Oxidized-LDL, LOX-1 and angiogenesis
氧化 LDL、LOX-1 和血管生成
基本信息
- 批准号:8195621
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-10-01 至 2013-09-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAntibodiesApoptosisAreaArterial Fatty StreakArteriesArtsAtherosclerosisBindingBiological AssayBlood VesselsBlood capillariesCD36 geneCell ProliferationCellsCessation of lifeCholesterolChronicCoronary arteryDataDevelopmentDiabetes MellitusDiabetic RetinopathyDyslipidemiasEmbryonic DevelopmentEndothelial CellsEventExtracellular Matrix DegradationFoam CellsFunctional disorderGenerationsGenesGrowthGrowth FactorHumanHydrogen PeroxideHypertensionInflammatoryIschemiaKnock-outKnockout MiceLDL Cholesterol LipoproteinsLOX geneLeadLectinLesionLow-Density LipoproteinsMalignant NeoplasmsMediatingMicroarray AnalysisModelingMolecularMolecular BiologyMusMyocardial InfarctionNecrosisOxidation-ReductionOxidative StressOxygenPathogenesisPathologicPhysiologicalPhysiological ProcessesPlayProcessReactive Oxygen SpeciesResearchRoleSignal TransductionSignaling MoleculeSmall Interfering RNASmokingSuperoxidesTestingTissuesTrainingTubeUp-RegulationVascular Endothelial Growth FactorsWorkWound Healingangiogenesisatherogenesisbasecapillarycardiovascular risk factorcell injurycell motilitydesignexperienceinhibitor/antagonistlow density lipoprotein inhibitormacrophagematrigelmembermigrationmouse modelneovasculaturenoveloxidized LDL receptorsoxidized low density lipoproteinpreconditioningpublic health relevancereceptorresearch studyresponsescavenger receptoruptake
项目摘要
Summary
Angiogenesis, defined as formation of new blood vessels, is a physiological process
necessary for embryonic development and wound repair. Angiogenesis is also an important
component of various pathologic events such as tissue ischemia, cancer, diabetic retinopathy,
and chronic inflammatory states including atherosclerosis. Among the key events leading to
angiogenesis is generation of reactive oxygen species (ROS) such as superoxide anions and
hydrogen peroxide which play a key role in physiological and pathophysiological states. LOX-1,
a lectin-like ox-LDL receptor, is responsible for binding and uptake of ox-LDL in endothelial
cells. It has been well documented that the activation of LOX-1 itself can stimulate the
formation of ROS and initiate a cascade of redox-sensitive signaling events. We postulate that
oxidized LDL (ox-LDL) at low concentrations activates LOX-1 in endothelial cells, induces low
levels of ROS release and initiates the angiogenic response.
Our specific aims in this proposal are:
Aim # 1: To study the effect of oxidized LDL (ox-LDL) on angiogenesis- These studies will
be done in human coronary artery endothelial cells, in an aortic ring model of angiogenesis, as
well as in wild-type and LOX-1 knock out (KO) mice.
Aim # 2: To define the mechanisms of ox-LDL-induced angiogenic response- These
studies will involve a number of specific inhibitors, LOX-1 antibody, siRNA against LOX-1, and
upregulation of LOX-1, and will involve state-of-art molecular biology approaches. Further, to
define the mechanism of the effects of ox-LDL, microarray technology will be utilized to identify
genes that are up-regulated and down-regulated during angiogenesis.
The strengths of the proposal are: 1. The PI has strong background on angiogenesis and
LOX-1 research. 2. The PI has LOX-1 KO mice in his possession. 3. Availability of well trained
molecular biologist well-versed in most aspects of the research. 4. One of the PI's team
members has extensive experience in microarray technology.
Significance: Understanding of the basis of formation of neovasculature may provide novel
information on the basis of atherogenesis, especially in the development of unstable lesions.
Information gained from this study may also have relevance in the development of cancers
which are dependent of neovasculature for their growth.
总结
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAWAHAR L MEHTA其他文献
JAWAHAR L MEHTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAWAHAR L MEHTA', 18)}}的其他基金
LOX-1, Angiogenesis and Atherosclerosis: Search for New Therapies.
LOX-1,血管生成和动脉粥样硬化:寻找新疗法。
- 批准号:
8542310 - 财政年份:2009
- 资助金额:
-- - 项目类别:
PCSK9-A novel target for the treatment of myocardial ischemia
PCSK9-治疗心肌缺血的新靶点
- 批准号:
10266760 - 财政年份:2009
- 资助金额:
-- - 项目类别:
PCSK9-A novel target for the treatment of myocardial ischemia
PCSK9-治疗心肌缺血的新靶点
- 批准号:
9896662 - 财政年份:2009
- 资助金额:
-- - 项目类别:
PCSK9-A novel target for the treatment of myocardial ischemia
PCSK9-治疗心肌缺血的新靶点
- 批准号:
10456121 - 财政年份:2009
- 资助金额:
-- - 项目类别:
LOX-1, Angiogenesis and Atherosclerosis: Search for New Therapies.
LOX-1,血管生成和动脉粥样硬化:寻找新疗法。
- 批准号:
8812715 - 财政年份:2009
- 资助金额:
-- - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
-- - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
-- - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for JSPS Fellows
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
-- - 项目类别: